Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Bullboard Posts
Comment by smush74on Mar 05, 2014 2:29pm
163 Views
Post# 22284452

RE:RE:RE:RE:Zacks analyst remarks

RE:RE:RE:RE:Zacks analyst remarks
yasman those are not my numbers or projections, Globe Investor/Reutors numbers. They is just some of  the tools I look at when I buy a stock and have it or plan to buy or hold. Morning star has it priced at fair value. I use them for input not advice. I have held DND since it went public, I got lucky when I took my initial investment and profit before they got hammered when the FDA refused their product years back.
I have always had my foot in the door at varring times and prices and will conitinue to do so. I don't tell anyone when to buy or sell or make any projetions.
My ins and out are my numbers that I live with and will continue the coarse, like I told wittman analysts are as reliable as weather forasters. I trust balance sheets and good mangement.

Thanks for naming Napando hadn't heard his name in a while.
good investing and fortunes
Bullboard Posts